Harrisburg, Pennsylvania; December 23rd, 2025
For years, families facing neurodegenerative disease have waited while research advanced unevenly, often dependent on private funding and federal grants that arrived slowly and selectively. This week, a different marker was set in Pennsylvania’s public record, as Josh Shapiro announced the Commonwealth’s first-ever state investment dedicated specifically to neurodegenerative disease research within the 2025-26 budget.
The announcement, issued through the Commonwealth of Pennsylvania, outlined a funding commitment designed to support research into conditions such as Alzheimer’s disease, Parkinson’s disease, ALS, and related neurological disorders. According to the governor’s office, the investment represents a structural shift, placing neurodegenerative research within the state’s budget priorities rather than treating it as an external or auxiliary concern.
The funding is intended to support Pennsylvania-based research institutions, universities, and medical centers engaged in studying the causes, progression, and potential treatments of neurodegenerative disease. The governor’s office described the initiative as both a health investment and an economic one, recognizing the Commonwealth’s role as home to a significant biomedical and research workforce.
Neurodegenerative diseases often advance quietly and relentlessly, reshaping lives over years rather than moments. The governor’s announcement framed the investment as a response to that reality, emphasizing that public institutions must engage not only in acute care, but also in long-term scientific efforts that seek understanding and intervention before decline becomes inevitable.
According to the release, the funding commitment aims to strengthen collaboration among researchers and accelerate progress by providing stable, predictable support. Rather than isolated grants, the state-backed approach is intended to create continuity, allowing research teams to plan multi-year studies and pursue complex questions that require sustained attention.
The governor’s office noted that Pennsylvania’s research universities and health systems are already active in neurological science, and that the new investment builds upon existing capacity rather than starting from scratch. By anchoring funding within the state budget, the initiative formalizes a partnership between public policy and medical research.
The announcement also acknowledged the personal dimension of neurodegenerative disease, referencing the toll such conditions take not only on patients, but on caregivers and families who often navigate years of progressive loss. The investment was framed as a step toward hope grounded in science, rather than promise unmoored from resources.
As part of the 2025–26 budget, the funding now enters the official ledger of the Commonwealth, where it will be administered and evaluated alongside other public investments. Its inclusion marks a departure from prior budgets, in which neurodegenerative disease research did not receive dedicated state funding.
Issued directly by the governor’s office, the announcement stands as the formal record of Pennsylvania’s entry into state-supported neurological research. It documents a moment when the Commonwealth moved from acknowledgment to action, committing public resources to a field defined by patience, persistence, and the long arc of discovery.
The Appalachian Post is an independent West Virginia news outlet dedicated to clean, verified, first-hand reporting. We do not publish rumors. We do not run speculation. Every fact we present must be supported by original documentation, official statements, or direct evidence. When secondary sources are used, we clearly identify them and never treat them as first-hand confirmation. We avoid loaded language, emotional framing, or accusatory wording, and we do not attack individuals, organizations, or other news outlets. Our role is to report only what can be verified through first-hand sources and allow readers to form their own interpretations. If we cannot confirm a claim using original evidence, we state clearly that we reviewed first-hand sources and could not find documentation confirming it. Our commitment is simple: honest reporting, transparent sourcing, and zero speculation.
Sources
Primary First-Hand Sources
- COMMONWEALTH OF PENNSYLVANIA, Office of the Governor release announcing first-ever state investment in neurodegenerative disease research within the 2025–26 budget, December 2025
Appalachian Post 
Leave a comment